Radnor Capital Management, LLC Bristol Myers Squibb CO Transaction History
Radnor Capital Management, LLC
- $598 Million
- Q4 2024
A detailed history of Radnor Capital Management, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Radnor Capital Management, LLC holds 80,866 shares of BMY stock, worth $4.64 Million. This represents 0.76% of its overall portfolio holdings.
Number of Shares
80,866
Previous 89,466
9.61%
Holding current value
$4.64 Million
Previous $4.63 Million
1.19%
% of portfolio
0.76%
Previous 0.69%
Shares
26 transactions
Others Institutions Holding BMY
# of Institutions
2,620Shares Held
1.46BCall Options Held
31.5MPut Options Held
34.9M-
Vanguard Group Inc Valley Forge, PA189MShares$10.8 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY159MShares$9.11 Billion0.15% of portfolio
-
State Street Corp Boston, MA92.9MShares$5.33 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY77.9MShares$4.47 Billion0.33% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA60.3MShares$3.46 Billion0.65% of portfolio
About BRISTOL MYERS SQUIBB CO
- Ticker BMY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 2,126,160,000
- Market Cap $122B
- Description
- Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...